Experimental Medication For the Treatment of Generalized Anxiety Disorder
Recruiting in Palo Alto (17 mi)
+49 other locations
Age: 18+
Sex: Any
Travel: May Be Covered
Time Reimbursement: Varies
Trial Phase: Phase 3
Waitlist Available
Sponsor: Jazz Pharmaceuticals
No Placebo Group
Pivotal Trial (Near Approval)
Prior Safety Data
Trial Summary
What is the purpose of this trial?
The purpose of this study is to determine whether an experimental anti-anxiety medication is effective in the treatment of Generalized Anxiety Disorder.
Research Team
MS
Murray Stein, MD
Principal Investigator
University of California, San Diego
Eligibility Criteria
Inclusion Criteria
Subjects 18 to 65 years of age will be eligible to participate if they satisfy the DSM-IV-TR criteria for the diagnosis of GAD.
Treatment Details
Interventions
- Experimental Anti-Anxiety Medication (Other)
Find a Clinic Near You
Research Locations NearbySelect from list below to view details:
Southwesten Research, Inc.Beverly Hills, CA
New Britain General HospitalNew Britain, CT
Diablo Clinical Research, Inc.Walnut Creek, CA
Sarkis Clinical TrialsGainsville, FL
More Trial Locations
Loading ...
Who Is Running the Clinical Trial?
Jazz Pharmaceuticals
Lead Sponsor
Trials
252
Patients Recruited
35,100+